These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27709615)

  • 1. Organ Chips: Quality Assurance Systems in Regenerative Medicine.
    Pasqualini FS; Emmert MY; Parker KK; Hoerstrup SP
    Clin Pharmacol Ther; 2017 Jan; 101(1):31-34. PubMed ID: 27709615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing challenges in regenerative medicine.
    Martin I; Simmons PJ; Williams DF
    Sci Transl Med; 2014 Apr; 6(232):232fs16. PubMed ID: 24739757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 4. Decision Support Tools for Regenerative Medicine: Systematic Review.
    Lam C; Meinert E; Alturkistani A; Carter AR; Karp J; Yang A; Brindley D; Cui Z
    J Med Internet Res; 2018 Dec; 20(12):e12448. PubMed ID: 30567696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms.
    Basu J; Assaf BT; Bertram TA; Rao M
    Toxicol Pathol; 2015 Jan; 43(1):115-25. PubMed ID: 25476796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
    Del Sol A; Okawa S; Ravichandran S
    Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of running a GMP facility for regenerative medicine in a public hospital.
    Viganò M; Giordano R; Lazzari L
    Regen Med; 2017 Oct; 12(7):803-813. PubMed ID: 29115906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010.
    Mason C; Manzotti E
    Regen Med; 2010 May; 5(3):307-13. PubMed ID: 20455641
    [No Abstract]   [Full Text] [Related]  

  • 11. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomimetic microsystems for cardiovascular studies.
    Inbody SC; Sinquefield BE; Lewis JP; Horton RE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C850-C872. PubMed ID: 33760660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The resolution of the XXVIII (91th) session of the RAMS General Meeting "Cell Technologies and Regenerative Medicine"].
    Dedov II; Tutel'ian VA
    Vestn Ross Akad Med Nauk; 2013; (9):4-6. PubMed ID: 24624865
    [No Abstract]   [Full Text] [Related]  

  • 15. Small molecules and small molecule drugs in regenerative medicine.
    Lu B; Atala A
    Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the human smooth muscle cell secretome for regenerative medicine.
    Justewicz DM; Shokes JE; Reavis B; Boyd SA; Burnette TB; Halberstadt CR; Spencer T; Ludlow JW; Bertram TA; Jain D
    Tissue Eng Part C Methods; 2012 Oct; 18(10):797-816. PubMed ID: 22530582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging stem cell based strategies for treatment of childhood diseases.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):311-315. PubMed ID: 29793820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency evaluation of tissue engineered and regenerative medicine products.
    Guthrie K; Bruce A; Sangha N; Rivera E; Basu J
    Trends Biotechnol; 2013 Sep; 31(9):505-14. PubMed ID: 23932143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in Cell Therapy and Regenerative Medicine for Neurological Disorders: Introduction to the ASNTR Special Issue From the 2016 Meeting.
    Borlongan CV
    Cell Transplant; 2017 Apr; 26(4):529-530. PubMed ID: 28403912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.